Cargando…

Exploration of the Associations of lncRNA Expression Patterns with Tumor Mutation Burden and Prognosis in Colon Cancer

BACKGROUND: Tumor mutation burden (TMB) is emerging as a new biomarker to monitor the response of cancer patients to immunotherapy. Long non-coding RNAs (lncRNAs) are critical in regulating gene expression and play a significant role in cancer-associated immune responses. However, the association be...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ding, Chengsheng, Shan, Zezhi, Li, Mengcheng, Xia, Yang, Jin, Zhiming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8096447/ https://www.ncbi.nlm.nih.gov/pubmed/33958876 http://dx.doi.org/10.2147/OTT.S300095

Ejemplares similares

Characterization of the fatty acid metabolism in colorectal cancer to guide clinical therapy
por: Ding, Chengsheng, et al.
Publicado: (2021)

A 7-lncRNA signature associated with the prognosis of colon adenocarcinoma
por: Fu, Xiaorui, et al.
Publicado: (2020)

The LncRNA XIRP2-AS1 predicts favorable prognosis in colon cancer
por: Zhou, Fengru, et al.
Publicado: (2019)

A Novel Tumor Mutation Burden Related lncRNA Signature Identified Prognosis and Tumor Immune Microenvironment Features in Clear Cell Renal Cell Carcinoma
por: Lin, Lin, et al.
Publicado: (2023)

Landscape of prognosis and immunotherapy responsiveness under tumor glycosylation-related lncRNA patterns in breast cancer
por: Lv, Wenchang, et al.
Publicado: (2022)

LncRNA ontology: inferring lncRNA functions based on chromatin states and expression patterns
por: Li, Yongsheng, et al.
Publicado: (2015)

Exploration of the relationship between tumor mutation burden and immune infiltrates in colon adenocarcinoma
por: Ouyang, Rong, et al.
Publicado: (2021)

Identification of lncRNA-mRNA Regulatory Module to Explore the Pathogenesis and Prognosis of Melanoma
por: Zhang, Jiaqi, et al.
Publicado: (2020)

Effect of Different Expression of Immune-Related lncRNA on Colon Adenocarcinoma and Its Relation to Prognosis
por: Mu, Meiwei, et al.
Publicado: (2020)

Identification of a Genome Instability-Associated LncRNA Signature for Prognosis Prediction in Colon Cancer
por: Yin, Tengfei, et al.
Publicado: (2021)

A cuproptosis-related lncRNA signature to predict prognosis and immune microenvironment of colon adenocarcinoma
por: Li, Dongming, et al.
Publicado: (2023)

Construction of disulfidptosis-related lncRNA signature for predicting the prognosis and immune escape in colon adenocarcinoma
por: Chen, Pan, et al.
Publicado: (2023)

Predicting the Immune Microenvironment and Prognosis with a NETosis-Related lncRNA Signature in Head and Neck Squamous Cell Carcinoma
por: He, Xiaohua, et al.
Publicado: (2022)

LncRNA CRNDE and lncRNA SNHG7 are Promising Biomarkers for Prognosis in Synchronous Colorectal Liver Metastasis Following Hepatectomy
por: Zhang, Peixian, et al.
Publicado: (2020)

An immune-related lncRNA signature for the prognosis of pancreatic adenocarcinoma
por: Qi, Bing, et al.
Publicado: (2021)

Identification of a ferroptosis-related lncRNA signature with prognosis for Wilms tumor
por: Liu, Hengchen, et al.
Publicado: (2021)

Surveying lncRNA-lncRNA cooperations reveals dominant effect on tumor immunity cross cancers
por: Shao, Tingting, et al.
Publicado: (2022)

A novel necroptosis-related lncRNA signature for predicting prognosis and immune response of colon cancer
por: Luo, Jian, et al.
Publicado: (2022)

Succinylation-associated lncRNA signature to predict the prognosis of colon cancer based on integrative bioinformatics analysis
por: Zhang, Si-ming, et al.
Publicado: (2023)

Identification of the 11-lncRNA signatures associated with the prognosis of endometrial carcinoma
por: Wan, Jing, et al.
Publicado: (2021)

Identification of Autophagy-Related LncRNA to Predict the Prognosis of Colorectal Cancer
por: Duan, Ling, et al.
Publicado: (2022)

LncRNA profile study reveals four-lncRNA signature associated with the prognosis of patients with anaplastic gliomas
por: Wang, Wen, et al.
Publicado: (2016)

lncRNA involvement in hepatocellular carcinoma metastasis and prognosis
por: Abbastabar, Maryam, et al.
Publicado: (2018)

lncRNA polymorphism affects the prognosis of gastric cancer
por: Lyu, Yanping, et al.
Publicado: (2022)

A lncRNA prognostic signature associated with immune infiltration and tumour mutation burden in breast cancer
por: Liu, Zijian, et al.
Publicado: (2020)

TP53 Mutation Related and Directly Regulated lncRNA Prognosis Markers in Hepatocellular Carcinoma
por: Zhang, Xiulei, et al.
Publicado: (2021)

High Expression of lncRNA AFAP1-AS1 Promotes the Progression of Colon Cancer and Predicts Poor Prognosis
por: Bo, Hao, et al.
Publicado: (2018)

Identification of a pyroptosis-related lncRNA risk model for predicting prognosis and immune response in colon adenocarcinoma
por: Tan, Yuying, et al.
Publicado: (2022)

Exploring the regulatory role of lncRNA in cancer immunity
por: Zhan, Dan-ting, et al.
Publicado: (2023)

A novel m7G-related lncRNA risk model for predicting prognosis and evaluating the tumor immune microenvironment in colon carcinoma
por: Yang, Sheng, et al.
Publicado: (2022)

A Novel Seventeen-Gene Metabolic Signature for Predicting Prognosis in Colon Cancer
por: Luo, Dakui, et al.
Publicado: (2020)

LncRNA profile study reveals a seven-lncRNA signature predicts the prognosis of patients with colorectal cancer
por: Huang, Rui, et al.
Publicado: (2020)

LncRNA Functional Screening in Organismal Development
por: Li, Yang, et al.
Publicado: (2023)

Integration analysis for novel lncRNA markers predicting tumor recurrence in human colon adenocarcinoma
por: Chen, Fangyao, et al.
Publicado: (2019)

Development and Validation of a Mutational Burden-Associated LncRNA Signature for Improving the Clinical Outcome of Hepatocellular Carcinoma
por: Xu, Mingjun, et al.
Publicado: (2021)

Tumor microenvironment immune-related lncRNA signature for patients with melanoma
por: Guo, Jia-Hui, et al.
Publicado: (2021)

Immune-Related lncRNA Pairs Clinical Prognosis Model Construction for Hepatocellular Carcinoma
por: Zhu, Yinghui, et al.
Publicado: (2022)

Circulating lncRNA EGFR-AS1 as a diagnostic biomarker of colorectal cancer and an indicator of tumor burden
por: Dai, Weiping, et al.
Publicado: (2022)

An Aggrephagy-Related LncRNA Signature for the Prognosis of Pancreatic Adenocarcinoma
por: Huang, Xueyuan, et al.
Publicado: (2023)

The role of lncRNA CASC2 on prognosis of malignant tumors: a meta-analysis and bioinformatics
por: Yu, Lingling, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_n2sg9nstm5uo2vlubmrqilsjqr